Redman J, Worthley L I
Department of Critical Care Medicine, Flinders Medical Centre, Adelaide, South Australia.
Crit Care Resusc. 2001 Mar;3(1):22-34.
To review the physiology and cardiovascular effects of the commonly used intravenous electrolytes.
Abstracts, articles and published reviews of studies reported from 1966 to 2000 and identified through a MEDLINE search on cardiac arrhythmias and electrolytes.
While isotonic saline solutions are used to improve the haemodynamic status in critically ill patients who are hypotensive and hypovolaemic, other intravenous solutions including potassium chloride, calcium chloride, magnesium sulphate and sodium or potassium phosphate as well as hypertonic saline and sodium bicabonate have unique and often therapeutically useful haemodynamic and antiarrhythmic effects. Potassium chloride solutions are used to treat hypokalaemia with a maximum speed of correction in an adult of 20 mmol per 30 minutes when an acute myocardial infarct is present. A greater infusion rate may be necessary when ventricular or supraventricular tachyarrhythmias are present although close ECG monitoring will be required. Magnesium sulphate (2-20 mmol) has been used for hypomagnesaemic and normomagnesaemic cardiac arrhythmias (particularly when digoxin induced) and calcium chloride (3.4-6.8 mmol) is used to treat hyperkalaemic and hypermagnesaemic cardiac arrhythmias. Both hypertonic sodium bicarbonate and sodium chloride solutions have antiarrhythmic effects that may be beneficial in conditions that include tricyclic poisoning, hyperkalaemia and bupivicaine toxicity, although sodium bicarbonate is generally used for tricyclic cardiotoxicity. Low cardiac output states and arrhythmias have also been reported in hypophosphataemic patients that are reversed by infusions of potassium or sodium phosphate.
Intravenous potassium chloride, calcium chloride, magnesium sulphate, sodium and potassium phosphate, sodium bicarbonate and hypertonic saline can be used effectively to alter the haemodynamic status and manage cardiac arrhythmias. However, their indications are selective and complications may occur, so careful administration and monitoring are required with their use.
综述常用静脉电解质的生理作用及心血管效应。
通过对1966年至2000年报道的研究进行MEDLINE检索,检索词为心律失常和电解质,从而获取摘要、文章及已发表的综述。
等渗盐溶液用于改善低血压和低血容量的危重症患者的血流动力学状态,而其他静脉溶液,包括氯化钾、氯化钙、硫酸镁、磷酸钠或磷酸钾,以及高渗盐水和碳酸氢钠,具有独特且通常具有治疗作用的血流动力学和抗心律失常作用。氯化钾溶液用于治疗低钾血症,当存在急性心肌梗死时,成人纠正低钾血症的最大速度为每30分钟20 mmol。当存在室性或室上性快速心律失常时,可能需要更高的输注速率,尽管需要密切监测心电图。硫酸镁(2 - 20 mmol)已用于低镁血症和正常镁血症的心律失常(特别是地高辛引起的),氯化钙(3.4 - 6.8 mmol)用于治疗高钾血症和高镁血症的心律失常。高渗碳酸氢钠溶液和氯化钠溶液均具有抗心律失常作用,在包括三环类中毒、高钾血症和布比卡因中毒等情况下可能有益,尽管碳酸氢钠通常用于三环类心脏毒性。低磷血症患者也有低心排血量状态和心律失常的报道,输注磷酸钾或磷酸钠可使其逆转。
静脉注射氯化钾、氯化钙、硫酸镁、磷酸钠和磷酸钾、碳酸氢钠和高渗盐水可有效改变血流动力学状态并处理心律失常。然而,它们的适应证具有选择性,且可能发生并发症,因此使用时需要谨慎给药和监测。